System and method for controlling focused ultrasound treatment
A system and method for controlling the delivery of ultrasound energy to a subject is provided. In particular, such a system and method are capable of safely disrupting the blood-brain barrier. Ultrasound energy is delivered to produce cavitation of an ultrasound contrast agent at a selected pressure value. An acoustic signal is acquired following cavitation, from which a signal spectrum is produced. The signal spectrum is analyzed for the presence of harmonics, such as subharmonics or ultraharmonics. When subharmonics or ultraharmonics are present, the pressure value is decreased for subsequent sonications. If a previous sonication resulted in no subharmonics or ultraharmonics being generated, then the pressure value may be increased. In this manner, the blood-brain barrier can be advantageously disrupted while mitigating potentially injurious effects of the sonication.
1. A focused ultrasound system comprising:
a transducer for delivering ultrasound energy to a subject;
a signal detector for detecting acoustic signals;
a processor in communication with the transducer and the signal detector,
the processor being configured to:
receive an acoustic signal from the signal detector;
produce a signal spectrum from the received acoustic signal;
analyze the produced signal spectrum to identify whether at least one of subharmonics and ultraharmonics are present therein;
select a pressure value setting using the analyzed signal spectrum by setting an initial value for the pressure value setting and after analyzing the signal spectrum:
increasing the pressure value setting until at least one of subharmonics and ultraharmonics are first identified in the signal spectrum; and
decreasing the pressure value setting according to a setting to a target level as a normalized value of pressure for the at least one of least one of subharmonics and ultraharmonics when at least one of subharmonics and ultraharmonics are identified in the signal spectrum; and
direct the transducer to generate ultrasound energy so as to produce cavitation of an ultrasound contrast agent at the selected pressure value setting.
2. The focused ultrasound system as recited in claim 1 in which the transducer includes a phased array transducer.
3. The focused ultrasound system as recited in claim 2 in which the phased array transducer includes at least one ultrasound receiver.
4. The focused ultrasound system as recited in claim 3 in which the at least one ultrasound receiver is configured to receive a signal and to communicate the received signal to the processor such that a location of the at least one of subharmonics and ultraharmonics identified in the signal spectrum can be determined therefrom.
5. The focused ultrasound system as recited in claim 2 in which the processor is further configured to adjust at least one of a phase, an amplitude, and a frequency of drive signals provided to the ultrasound transducer so as to control an extent of the ultrasound energy generated by the ultrasound transducer.
6. The focused ultrasound system as recited in claim 1 in which the processor is further configured to use information related to whether at least one of sub harmonics and ultraharmonics were identified in the signal spectrum to adjust at least one of a frequency, a burst length, a pulse repetition frequency, a sonication start time, a sonication end time, and a sonication duration.
7. The focused ultrasound system as recited in claim 1 in which the transducer is configured to surround an extent of a head of the subject.
8. The focused ultrasound system as recited in claim 1 in which the processor is further configured to:
use the received acoustic signal to determine whether an ultrasound contrast agent is circulating through a volume-of-interest in the subject; and
adjust the selected pressure value setting using information related to whether an ultrasound contrast agent is circulating through the volume-of-interest in the subject.
9. The focused ultrasound system as recited in claim 1 in which the processor is configured to analyze the produced signal spectrum at a fundamental frequency of the produced signal spectrum in order to determine whether an ultrasound contrast agent is circulating through a volume-of-interest in the subject.